NPC1 is a rare pediatric dementia that leads to severe neuronal degeneration. NPC1 shares clinical and pathological features with Alzheimer׳s disease (AD). Approaches using animal models have not rendered an FDA-approved therapy. Autophagy disruption may play a key role in NPC1 pathogenesis. Genome editing and human stem cells can accelerate drug discovery in NPC1.